Drugs / TRN-157
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02133339 | May → Aug 2014 | chronic obstructive pulmonary disease | Theron Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02382510 | Apr 2015 → Mar 2016 | asthma | Theron Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRN-157 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02382510 ↗ |
| Route | Inhaled | “Nebulized, TRN-157 Inhalation Solution” NCT02133339 ↗ |